Scilex Holding Company
Scilex Holding Company SCLXW Peers
See (SCLXW) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SCLXW | $0.10 | -6.28% | 31.4M | N/A | N/A | N/A |
| LLY | $807.86 | -1.40% | 765.6B | 65.73 | $12.29 | +0.69% |
| AZN | $73.55 | -1.17% | 456.1B | 29.54 | $2.49 | +2.10% |
| JNJ | $155.26 | -1.17% | 373.6B | 17.27 | $8.99 | +3.25% |
| NVO | $77.03 | -3.51% | 344.1B | 21.28 | $3.62 | +2.10% |
| ABBV | $190.86 | -0.12% | 337.1B | 80.87 | $2.36 | +3.35% |
| NVS | $118.14 | -1.10% | 233.3B | 18.52 | $6.38 | +3.38% |
| MRK | $80.98 | -0.90% | 203.3B | 11.49 | $7.05 | +4.93% |
| AMGN | $295.56 | +0.12% | 158.9B | 26.92 | $10.98 | +3.14% |
| PFE | $24.41 | -0.55% | 138.8B | 17.68 | $1.38 | +6.99% |
Stock Comparison
SCLXW vs LLY Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, LLY has a market cap of 765.6B. Regarding current trading prices, SCLXW is priced at $0.10, while LLY trades at $807.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas LLY's P/E ratio is 65.73. In terms of profitability, SCLXW's ROE is +0.36%, compared to LLY's ROE of +0.77%. Regarding short-term risk, SCLXW is less volatile compared to LLY. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs AZN Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, AZN has a market cap of 456.1B. Regarding current trading prices, SCLXW is priced at $0.10, while AZN trades at $73.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AZN's P/E ratio is 29.54. In terms of profitability, SCLXW's ROE is +0.36%, compared to AZN's ROE of +0.19%. Regarding short-term risk, SCLXW is less volatile compared to AZN. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs JNJ Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, JNJ has a market cap of 373.6B. Regarding current trading prices, SCLXW is priced at $0.10, while JNJ trades at $155.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas JNJ's P/E ratio is 17.27. In terms of profitability, SCLXW's ROE is +0.36%, compared to JNJ's ROE of +0.30%. Regarding short-term risk, SCLXW is less volatile compared to JNJ. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs NVO Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, NVO has a market cap of 344.1B. Regarding current trading prices, SCLXW is priced at $0.10, while NVO trades at $77.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVO's P/E ratio is 21.28. In terms of profitability, SCLXW's ROE is +0.36%, compared to NVO's ROE of +0.81%. Regarding short-term risk, SCLXW is less volatile compared to NVO. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs ABBV Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, ABBV has a market cap of 337.1B. Regarding current trading prices, SCLXW is priced at $0.10, while ABBV trades at $190.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas ABBV's P/E ratio is 80.87. In terms of profitability, SCLXW's ROE is +0.36%, compared to ABBV's ROE of +0.96%. Regarding short-term risk, SCLXW is less volatile compared to ABBV. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs NVS Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, NVS has a market cap of 233.3B. Regarding current trading prices, SCLXW is priced at $0.10, while NVS trades at $118.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVS's P/E ratio is 18.52. In terms of profitability, SCLXW's ROE is +0.36%, compared to NVS's ROE of +0.31%. Regarding short-term risk, SCLXW is less volatile compared to NVS. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs MRK Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, MRK has a market cap of 203.3B. Regarding current trading prices, SCLXW is priced at $0.10, while MRK trades at $80.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MRK's P/E ratio is 11.49. In terms of profitability, SCLXW's ROE is +0.36%, compared to MRK's ROE of +0.38%. Regarding short-term risk, SCLXW is less volatile compared to MRK. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs AMGN Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, AMGN has a market cap of 158.9B. Regarding current trading prices, SCLXW is priced at $0.10, while AMGN trades at $295.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AMGN's P/E ratio is 26.92. In terms of profitability, SCLXW's ROE is +0.36%, compared to AMGN's ROE of +0.93%. Regarding short-term risk, SCLXW is less volatile compared to AMGN. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs PFE Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, PFE has a market cap of 138.8B. Regarding current trading prices, SCLXW is priced at $0.10, while PFE trades at $24.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas PFE's P/E ratio is 17.68. In terms of profitability, SCLXW's ROE is +0.36%, compared to PFE's ROE of +0.09%. Regarding short-term risk, SCLXW is less volatile compared to PFE. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs GILD Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, GILD has a market cap of 137.9B. Regarding current trading prices, SCLXW is priced at $0.10, while GILD trades at $110.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GILD's P/E ratio is 14.32. In terms of profitability, SCLXW's ROE is +0.36%, compared to GILD's ROE of +0.32%. Regarding short-term risk, SCLXW is less volatile compared to GILD. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs SNY Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, SNY has a market cap of 121.2B. Regarding current trading prices, SCLXW is priced at $0.10, while SNY trades at $49.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SNY's P/E ratio is 17.40. In terms of profitability, SCLXW's ROE is +0.36%, compared to SNY's ROE of +0.08%. Regarding short-term risk, SCLXW is less volatile compared to SNY. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs CELG-RI Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, CELG-RI has a market cap of 113.2B. Regarding current trading prices, SCLXW is priced at $0.10, while CELG-RI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SCLXW's ROE is +0.36%, compared to CELG-RI's ROE of +0.32%. Regarding short-term risk, SCLXW is less volatile compared to CELG-RI. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs BMY Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, BMY has a market cap of 99B. Regarding current trading prices, SCLXW is priced at $0.10, while BMY trades at $48.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BMY's P/E ratio is 17.82. In terms of profitability, SCLXW's ROE is +0.36%, compared to BMY's ROE of +0.32%. Regarding short-term risk, SCLXW is less volatile compared to BMY. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs GSK Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, GSK has a market cap of 82.1B. Regarding current trading prices, SCLXW is priced at $0.10, while GSK trades at $40.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GSK's P/E ratio is 19.66. In terms of profitability, SCLXW's ROE is +0.36%, compared to GSK's ROE of +0.22%. Regarding short-term risk, SCLXW is less volatile compared to GSK. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs HZNP Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, SCLXW is priced at $0.10, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas HZNP's P/E ratio is 61.86. In terms of profitability, SCLXW's ROE is +0.36%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, SCLXW is less volatile compared to HZNP. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs BIIB Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, BIIB has a market cap of 19.2B. Regarding current trading prices, SCLXW is priced at $0.10, while BIIB trades at $131.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BIIB's P/E ratio is 12.94. In terms of profitability, SCLXW's ROE is +0.36%, compared to BIIB's ROE of +0.09%. Regarding short-term risk, SCLXW is less volatile compared to BIIB. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs GRFS Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, GRFS has a market cap of 7.5B. Regarding current trading prices, SCLXW is priced at $0.10, while GRFS trades at $9.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GRFS's P/E ratio is 34.96. In terms of profitability, SCLXW's ROE is +0.36%, compared to GRFS's ROE of +0.03%. Regarding short-term risk, SCLXW is less volatile compared to GRFS. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs OGN Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, OGN has a market cap of 2.7B. Regarding current trading prices, SCLXW is priced at $0.10, while OGN trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas OGN's P/E ratio is 3.54. In terms of profitability, SCLXW's ROE is +0.36%, compared to OGN's ROE of +1.82%. Regarding short-term risk, SCLXW is less volatile compared to OGN. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs CTOR Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, CTOR has a market cap of 99.5M. Regarding current trading prices, SCLXW is priced at $0.10, while CTOR trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CTOR's P/E ratio is -3.66. In terms of profitability, SCLXW's ROE is +0.36%, compared to CTOR's ROE of -0.15%. Regarding short-term risk, SCLXW is less volatile compared to CTOR. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs SCLX Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, SCLX has a market cap of 33.3M. Regarding current trading prices, SCLXW is priced at $0.10, while SCLX trades at $4.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SCLX's P/E ratio is -0.31. In terms of profitability, SCLXW's ROE is +0.36%, compared to SCLX's ROE of +0.36%. Regarding short-term risk, SCLXW is less volatile compared to SCLX. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs MIRA Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, MIRA has a market cap of 21.1M. Regarding current trading prices, SCLXW is priced at $0.10, while MIRA trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MIRA's P/E ratio is -2.66. In terms of profitability, SCLXW's ROE is +0.36%, compared to MIRA's ROE of -3.41%. Regarding short-term risk, SCLXW is less volatile compared to MIRA. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs SRXH Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, SRXH has a market cap of 6.9M. Regarding current trading prices, SCLXW is priced at $0.10, while SRXH trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SRXH's P/E ratio is N/A. In terms of profitability, SCLXW's ROE is +0.36%, compared to SRXH's ROE of -0.50%. Regarding short-term risk, SCLXW is less volatile compared to SRXH. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.
SCLXW vs CRXT Comparison
SCLXW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 31.4M. In comparison, CRXT has a market cap of 0. Regarding current trading prices, SCLXW is priced at $0.10, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CRXT's P/E ratio is -0.02. In terms of profitability, SCLXW's ROE is +0.36%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, SCLXW is less volatile compared to CRXT. This indicates potentially lower risk in terms of short-term price fluctuations for SCLXW.